Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Public & Community Psychiatry
•
General Outpatient Psychiatry
•
Psychotic Disorders
•
Psychopharmacology
When do you consider using Uzedy, the subcutaneous long-acting injectable version of risperidone?
Related Questions
How do you monitor patients who are symptomatically well-managed on clozapine with supratherapeutic drug levels?
How do you transition patients between different long-acting injectable antipsychotics?
What are the most effective strategies for managing weight gain associated with antipsychotic medications?
How do you approach firearm safety counseling for outpatients with elevated suicide risk who do not meet criteria for involuntary psychiatric hospitalization?
How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?
When do you use seizure prophylaxis in patients on clozapine?
How will the removal of the clozapine REMS requirement change your clinical practice?
How do you approach deprescribing anticholinergics in patients with psychotic disorders?
Have you observed adverse mental health side effects in patients who start montelukast?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (PRN) if/when symptoms develop?
